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ABSTRACT
Naive T cells after allogeneic hematopoietic cell transplantation are thought to originate from the engrafted
hematopoietic cells. In this report, we show that there is a correlation between the number of naive CD4 T
cells infused with peripheral blood stem cell grafts and the absolute number of peripheral naive CD4 T cells
on day 30 (R  0.65; P < .001), day 80 (R  0.63; P < .001), and day 180 (R  0.66; P < .001) after
transplantation. These results suggest that in the first 6 months after transplantation, most naive CD4 T cells
are derived from the naive T cells infused with the graft.
© 2003 American Society for Blood and Marrow Transplantation
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ﬁNTRODUCTION
Reconstitution of T cells after hematopoietic cell
ransplantation may occur either through de novo
eneration (from grafted hematopoietic cells) or pe-
ipheral expansion (of T cells infused with the graft;
ee reviews [1-3]). Generation of T cells de novo is
inimal in the ﬁrst 3 months after hematopoietic cell
ransplantation and leads to increasing numbers of
aive T cells only thereafter [4-9]. However, pheno-
ypically naive T cells are present in the ﬁrst 3 months
fter transplantation [10,11]. These cells may be de-
ived from the naive T cells infused with the graft; we
resent data in this report to support this hypothesis.
ATIENTS AND METHODS
We determined mononuclear cell (MNC) subsets
n the grafts and in the peripheral blood of 122 allo-
eneic transplant recipients at least once during the
rst year after transplantation. We selected for this
tudy 102 patients who did not die before 1 month
fter transplantation and who did not relapse by 1 year
fter transplantation. The reason for excluding pa-
ients with relapse was the fact that these patients were t
B&MTsually treated with chemotherapy, which could de-
rease T-cell counts, or could have received donor
ymphocyte infusion, which could increase T-cell
ounts. Thirty-nine patients received ﬁlgrastim-mo-
ilized peripheral blood stem cells (PBSC), and 63
atients received marrow [12]. Demographic and clin-
cal characteristics of the patients are displayed in
able 1. All patients underwent transplantation for
ematologic malignancies. For all patients, it was their
rst allogeneic transplantation. All conditioning regi-
ens were myeloablative, typically intravenous cyclo-
hosphamide (120 mg/kg) with oral busulfan (approx-
mately 16 mg/kg) or intravenous cyclophosphamide
120 mg/kg) with fractionated total body irradiation
12.0-13.2 Gy). All patients received graft-versus-host
isease prophylaxis with methotrexate (days 1, 3, 6,
nd 11) and cyclosporine (for 6 months, except for
atients with clinical extensive chronic graft-versus-
ost disease). The study was approved by the Fred
utchinson Cancer Research Center Institutional Re-
iew Board.
Enumeration of MNC subsets was performed by
-color ﬂow cytometry as described previously
11,13]. Most patients participated in a randomizedoi:10.1016/j.bbmt.2003.09.003m
p
i
(
(
d
a
p
h
H
v
3
[
rial of PBSC versus marrow transplantation [12]; for
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these patients, the numbers of MNC subsets in the
grafts and in the blood after transplantation have been
reported [11]. Naive CD4 T cells were deﬁned as
CD45RAhigh CD4 T cells because this subset has been
shown to contain thymic emigrants, and nearly all
cord blood CD4 T cells are CD45RAhigh [10,14,15].
Naive CD8 T cells were deﬁned as CD11alow CD8 T
cells because virtually all cord blood CD8 T cells are
CD11alow and become CD11ahigh after activation
[16,17]. Moreover, after transplantation CD45RAhigh
CD4 T-cell counts correlate with T-cell receptor ex-
cision circle–containing CD4 T-cell counts, and
CD11alow CD8 T-cell counts correlate with T-cell
receptor excision circle–containing CD8 T-cell
counts [8].
Signiﬁcance of correlation was tested by Spearman
nonparametric tests. Correlations with P  .05 were
considered signiﬁcant.
RESULTS AND DISCUSSION
There was a signiﬁcant correlation between the
numbers of naive CD4 T cells in the PBSC graft and
in the peripheral blood on days 30, 80, and 180 (Table
2, Figure 1). A similar correlation or trend toward a
correlation was observed for the numbers of naive
CD8 T cells in the PBSC graft and in the peripheral
blood (Table 2, Figure 1). For naive CD4 or CD8 T
cells in the marrow graft, the correlation was weak or
nonexistent (Table 2), possibly because of a small
sample size (the lower the number of cells, the greater
the variability of the measurement; thus, a very large
sample size would be needed to detect a correlation
between the relatively low numbers of naive T cells in
the marrow grafts and in the peripheral blood after
transplantation). There was no signiﬁcant correlation
between the number of CD34 cells in the PBSC or
marrow graft and the number of naive CD4 or CD8 T
cells after transplantation (data not shown). The lack
of correlation might be due to the fact that for the ﬁrst
several months after transplantation, most naive T
cells do not originate from hematopoietic progenitors.
Later, the number of de novo–generated T cells de-
pends primarily on the thymic function rather than on
the number of hematopoietic progenitors.
Concerning MNC subsets other than naive T
Table 1. Patient Characteristics
Variable
PBSC Recipients
(n  39)
Marrow Recipients
(n  63)
Age in y, median (range) 45 (17-61) 42 (20-60)
Sex (male/female) 26/13 36/27
Donor (HLA-matched sibling/another HLA-matched relative) 39/0 62/1
Cytomegalovirus serostatus (positive/negative) 23/16 30/33
Acute GVHD (grade 0–I/grade II–IV*/unknown) 8/30/1 15/48/0
Chronic GVHD (none or clinical limited/clinical extensive†/not applicable [death by day 100]) 9/26/4 17/39/7
Chimerism‡ (complete/incomplete/unknown) 25/0/14 32/1/30
GVHD indicates graft-versus-host disease.
*Typically treated with prednisone 1 to 2 mg/kg/d orally for 10 to 14 days with subsequent taper over 50 days.
†Typically treated with prednisone (0.5-1.0 mg/kg every other day by month) plus cyclosporine (approximately 6 mg/kg every other day by
month) for at least 9 months.
‡Complete chimerism was deﬁned as 90% marrow cells of donor origin by day 80. In the one patient with incomplete chimerism, 88% of
marrow cells were of donor origin on day 80.
Table 2. Correlation between the Number of Naive T Cells in the Graft (per Kilogram Recipient Body Weight) and the Number of Naive T Cells
after Transplantation (per Microliter of Blood)
Variable
PBSC Graft Marrow Graft
Day 30 Day 80 Day 180 Day 365 Day 30 Day 80 Day 180 Day 365
CD4
R* .65 .63 .66 .25 .25 .31 .24 .21
P† <.001 <.001 <.001 NS .05 .02 NS NS
n‡ 37 32 26 26 63 55 38 38
CD8
R .32 .37 .36 .24 .11 .21 .10 .21
P .06 .04 .07 NS NS NS NS NS
n 37 32 26 27 61 54 38 38
*Spearman rank correlation coefﬁcient.
†P value is given when it is .07. Not signiﬁcant (NS) indicates P values .07.
‡Number of patients studied.
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cells, there was no signiﬁcant correlation between the
number of memory/effector (CD45RAlow/ CD4 or
CD11ahigh CD8) T cells in the PBSC or marrow graft
and in the blood on days 30, 80, 180, or 365 after
transplantation (data not shown), except for
CD45RAlow/ CD4 T cells in the PBSC graft and in
blood on day 180 (R  .44; P  .02). The reason for
the lack of correlation may be that after transplanta-
tion, the grafted memory/effector T-cell clones un-
dergo expansion that depends on the encounter with
their cognate antigen (eg, viral or alloantigen) rather
than on the number of grafted T cells. There was no
signiﬁcant correlation between the number of mono-
cytes or natural killer cells in the PBSC or marrow
graft and in the blood on days 30, 80, 180, and 365
after transplantation (data not shown). For B cells,
there was a correlation or a trend toward a correlation
between the number of B cells in the PBSC (but not
marrow) graft and in peripheral blood on day 30 (R 
.38; P  .02) and day 80 (R  .30; P  .11) but not
later after transplantation. Thus, early after PBSC
transplantation, some B cells may originate from the B
cells infused with the graft.
In conclusion, in the ﬁrst 6 months after trans-
plantation, most naive T cells seem to originate from
the naive T cells infused with the graft.
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